Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Human Molecular Genetics|February 17, 2017
Remodelling of microRNAs in colorectal cancer by hypoxia alters metabolism profiles and 5-fluorouracil resistanceAnke Nijhuis, Hannah Thompson, Julie Adam, et al.
British Journal of Cancer|February 14, 2018
A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinomaNatalie Cook, Bristi Basu, Donna-Michelle Smith, et al.
Redox Biology|November 6, 2025
Phase IB trial of high dose ascorbic acid + nab-paclitaxel + cisplatin + gemcitabine in patients with untreated metastatic pancreatic cancerGayle S Jameson, S Danielle LeGrand, Michael S Gordon, et al.
Clinical Endocrinology|April 19, 2008
Clinical manifestations of familial paraganglioma and phaeochromocytomas in succinate dehydrogenase B (SDH-B) gene mutation carriersUmasuthan Srirangalingam, Lisa Walker, Bernard Khoo, et al.
Endocrine-Related Cancer|February 12, 2009
Contrasting clinical manifestations of SDHB and VHL associated chromaffin tumoursUmasuthan Srirangalingam, Bernard Khoo, Lisa Walker, et al.
The Lancet. Oncology|June 7, 2011
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trialRichard A Adams, Angela M Meade, Matthew T Seymour, et al.
Nature Communications|August 18, 2018
The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent mannerMette Ø Agerbæk, Sara R Bang-Christensen, Ming-Hsin Yang, et al.
The Lancet. Oncology|March 6, 2017
Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trialGary Middleton, Daniel H Palmer, William Greenhalf, et al.
Cancer Discovery|June 30, 2022
A Therapeutically Actionable Protumoral Axis of Cytokines Involving IL-8, TNFα, and IL-1βIrene Olivera, Rebeca Sanz-Pamplona, Elixabet Bolaños, et al.
Oncotarget|May 12, 2016
Relative telomere lengths in tumor and normal mucosa are related to disease progression and chromosome instability profiles in colorectal cancerNirosha Suraweera, Dmitri Mouradov, Shan Li, et al.
Pageof 9